SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Despite strong earnings and positive AI outlook, Broadcom (AVGO) is trending down, driven by concerns over margin compression and a broader tech sector pullback. Community chatter highlights disappointment in the stock's reaction to earnings, with some suspecting market manipulation and a potential AI bubble. Investors are debating whether to buy the dip or brace for further declines, while analysts remain largely bullish on the stock's long-term potential.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to discussions around its low float and potential for a short squeeze, with community members comparing it to other high-flying stocks. Traders are actively watching key resistance levels and speculating on possible price targets, while also weighing concerns about the company's valuation and potential for a pullback. The stock's association with the robotics sector and its connection to AMC through its name are also contributing to the ongoing conversation.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco ($COST) is trending due to a recent analyst downgrade from Roth Capital, sparking debate about its valuation and growth prospects, especially compared to competitors like Walmart. The community is discussing whether this presents a buying opportunity or signals deeper concerns about membership growth and market saturation. Some investors are also closely watching for any news regarding a potential stock split or special dividend announcement.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to community excitement around its potential for a short squeeze, with many noting bullish technical formations and anticipating a breakout. The stock is also gaining attention due to positive interim data from its RAD 101 clinical trial, leading to speculation about future sales and potential buyout offers. Community members are actively discussing target prices and the possibility of the stock reaching significantly higher levels.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation that the cannabis industry could be on the verge of significant reform, with community members closely watching for potential executive action. The central talking point revolves around the possibility of reclassification, with many expressing mixed sentiment due to the long history of the stock. Despite the hype, some traders are wary, pointing to past disappointments.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chun Sing Chan on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to its nano float and Hong Kong connection, with traders anticipating a potential run similar to other low-float stocks. Community members cite recent acquisitions and revenue growth as catalysts, while also highlighting its low market capitalization. The stock's high borrow rate and potential for a short squeeze are also fueling interest.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

ARTV is trending as traders discuss a recent FDA Fast Track designation for its AlloNK therapy in refractory rheumatoid arthritis, with Wedbush setting a price target. Community members highlight the potential for a significant squeeze, referencing low float and high borrow rates. Some caution around potential offerings and the stock's volatile price action.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending amid community chatter about a potential short squeeze, with comparisons being drawn to other low-float runners. The stock's price action and thin float are fueling speculation, as traders closely monitor key levels for potential breakouts. Some caution exists due to the company's non-US location.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending as investors assess the implications of its AI strategy and recent partnerships, with community discussions focusing on whether the company can maintain its growth trajectory amidst rising competition. Recent reports of a potential acquisition of cybersecurity firm Armis for $7B has sparked debate about valuation and strategic fit, contributing to market volatility. Despite long-term bullish sentiment from analysts, the stock's YTD performance has some questioning its current valuation and potential for short-term recovery.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

GLSI is trending as analysts have recently updated target price forecasts, sparking discussions around valuation and potential acquisition targets. Community members are debating whether current price action represents a buying opportunity, while others discuss the possibility of future dilution. Bullish sentiment surrounds the drug's clinical profile and potential for a licensing deal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nyxoah (NASDAQ:NYXH) Trading Down 2.9% - Here's What Happened

Nyxoah (NASDAQ:NYXH) Shares Down 2.9% - Should You Sell...

Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System

Nyxoah secures a finalized CMS rule that sharply lifts 2026 reimbursement for Genio implants, opening fresh momentum for its OSA therapy.

<ul class="summary-bullets"><li>Under the new rule, Hospital Outpatient Department (HOPD) reimbursement for Nyxoah’s Genio hypoglossal nerve stimulation implants will increase to approximately $45,000 starting in 2026.</li><li>According to Nyxoah, the Genio procedure is well-suited for the ASC environment, and the new rules create new opportunities for site-of-service diversification as well.</li></ul><p>Shares of Nyxoah SA (NYXH) jumped 7% in the pre-market session on Wednesday after the company said that its Genio Therapy would benefit from the new medicare reimbursement criteria for CY2026.</p><p>The U.S. Centers for Medicare &amp; Medicaid Services (CMS) finalized its CY2026 medicare reimbursement rules on Friday.</p><h2 class="st-heading-2">How Will It Aid Nyxoah?</h2><p>Under the new rule, Hospital Outpatient Department (HOPD) reimbursement for Nyxoah’s Genio hypoglossal nerve stimulation implants for the treatment of Obstructive Sleep Apnea will increase to approximately $45,000 starting in 2026, a 48% rise compared to 2025, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/11/26/3194857/0/en/Nyxoah-s-Genio-Therapy-Receives-Significant-2026-Medicare-Reimbursement-Increases-Under-Final-CMS-Rule.html">said</a>. Ambulatory Surgery Centers (ASC) facility reimbursement, meanwhile, will increase to $42,373, reflecting a 58% increase compared to 2025.</p><p>Nyxoah expects the stronger reimbursement framework to support broader adoption, increase procedural throughput, and expand across Medicare-heavy institutions. Further, the procedure is well-suited for the ASC environment, and the change in rules creates new opportunities for therapy expansion and site-of-service diversification, the company added.</p><h2 class="st-heading-2">Others To Benefit From New Rules</h2><p>The new rules apply to Nyxoah’s peers, too. Earlier this week, Stifel analyst Jonathan Block upgraded Inspire Medical Systems (INSP) to ‘Buy’ from ‘Hold’ while also hiking the price target to $110, up from $100.</p><p>Inspire Medical makes the Inspire V implant to treat obstructive sleep apnea. It is installed in an approximate 60-minute outpatient procedure. According to the Stifel analyst, the company's headwinds are easing following CMS's positive reimbursement revision on Friday.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>On Stocktwits, retail sentiment around NYXH fell from ‘bullish’ to ‘neutral’ territory over the past 24 hours while message volume rose from ‘low’ to ‘high’ levels.</p><figure class="image"><img style="aspect-ratio:624/60;" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAwgAAABLCAYAAADUIaBIAAAQAElEQVR4AeydDVhU19Xv/8M3DAwDCoLRKJYoosSqsfEjxgZr3qteU41GvdJog0qj0bTW9O1tYu9N+5g8fVJtbqtRE6O5mqvRV0VTX6VXEzQaDRoVDQqoKCDooOIwDJ/D57vXmRkYhq8zH8CAi+fsOefsvfbae//msNZZZ59zxq2e/5gAE2ACTIAJMAEmwASYABNgAiYCbuA/JsAEeigBHhYTYAJMgAkwASbABGwnICtAKC+vhFZbjPv3H+HevYecmAEfA3wM8DHggscA2Wiy1WSzbXcH9teg9qhdap99RCf5SBc8/vi75++ejwHXPgbIRpOtJpvdnsVvM0AgBaSsstIAHx9v9O4dhPDw3ujbN4QTM+BjgI8BPgZc6Bgg20w2mmw12Wyy3WTD23MCjpSTfmqH2qN2qX3qB/sI9pF8DPAxwMeA/cdAR7Aj20w2mmw12Wyy3WTDW/MBrQYIxcWlKCurgFqtQnBwIPz8fODu7gaFQtGaLs5nAkyACTCBLiKgUCgkG022mmw22W6y4WTL0QF/pJf0UzvUHrXLPqIDQLNKJsAEmIATCCgUCpt8hBta+CPDX1tbK2YM1PD29mxBgrOYABNomwCXMoGuJUC2u3dvNciWk013Zm9IH+kl/dSOM3WzLibABJgAE+h4AmS7yYaTLSebbt1iswCBphuqqqoRFKTi2QJrWrzPBJgAE+hGBBQKhWTLyaaTbXdG10kP6XusfYQzQLIOJsAEmEAXE1AoWvcRzQKEkpIyqFT+HBx08ZfGzTMBJsAEnEFAoVBINp1suzP0kR72Ec4gyTqYABNwRQKPW58UipZ9RJMAga4MeXp68G1Fj9vRweNlAkygRxOgqWSy7WTjHRko1Sc9pM8RPVyXCTABJsAEXIcA2XSy7WTjzb1qEiDQU830dLO5kNdMoHsS4F4zASZgTYBsO9l463xb9qk+6bGlDssyASbABJiA6xMg20423tzTJgFCdXWNmD3wMpfxmgkwASbABHoIAW9vL5CNd2Q4VJ/0OKLD4bqsgAkwASbABJxOgGw72Xiz4iYBQm1tHdzc+DWmZji8ZgJMgAn0FAJk28nGOzIeqk96HNHBdZkAE2ACrRHg/K4jQLadbLy5B00CBMpUKDhAIA6cmAATYAI9iYBC4RzbrlA4R09PYstjYQJMgAl0dwIKRVPb3ixA6O4D5P53NQFunwkwASbABJgAE2ACTKA7E+AAoTt/e9x3JsAEmEBnEuC2mAATYAJM4LEgwAHCY/E18yCZABNgAkyACTABJtA6AS5hApYEun+AoM/H1RtFlmPibSbABJgAE2AC3Y9AbgoOHUxBXvfrOfeYCTCBHkbA6QFCWdY32LNlIz78UKS/b8b2g6l4UO0savk4a2U8s04fxvGkb3HVWU3YqocM+tl8W2t1kDyrZQJMgAm4MIGHKdi1ZSu2Jze3mZlHt2PTliRkunD32+xadRoObdmOpCxrqQKc2rkV+y+UWxc039cVIDunANrmJZzDBJgAE+hUAs4NELQp2H8kHRg5EwkrVmD5L6ZhGNJx6preOYPS5eOmlfGMnBqP+CXTMNw5LdispTj/FrLv8QyGzeC4AhNwIQIGQxWKiopx714BsrKyce3adVy5cg2XLqXh++8vIyXlorS+dOkHKZ/Kb97Mxt27BaKeDgaDoeNH0xNaqDHAUF2DshvpyLYcT90NZN4uh6FClFvmd6dtz8EIV5UjOyu3aa+1t5D9yA99I/2a5vMeE2AC3YZAbW0tKiurUFpaLmy+HoWFOjx4oMX9+4+g0RQK3/FQWtM+5VN5UZFekqd6VL/bDNbUUecGCHkF0PoOwYRn+0HpCXj3GoBnZ8Vhzo9VpuZoVQvt7XRcvJSKq7eLUENZpmTQ61FGsw1025Aov5iWj+I6U2F1OYof6GEQNSp1ehTrysWWKKsWjrm2UUszHdcfGuXq9MhLSxXt3mg+o1FngOY6laUiUyP0CbXGpRZloi2D6EPN/RuirpAx6xMCNWV6PCwR8sLpFQu54rJakcsLE2ACrk6gvr5eGHsDdLoS1NTUIjU1DdevZ+HOnbvC8GtRUlKKiopKVFVVwWzYaV1VVS3lU/mjR1rk5d0V9W6J+ldRXl4Jvb5U1CEj5uoEurB/PiEI8cxFZo5FH9JEwNA7DKEWWcbN2lb9BaofIpP8hEiZ95va3uJco49p4kNIofAjeSZbfzW3+YUrg8Zs54XvIZsukuSTqG6rfoIKKXkjakAQDHdzoKFdUyrOyIE2eCCi1KYMCz0t9cEkZVwZ9GjqV2oln9TQJzGeYr3wQajFA2lc6cgzDcvss1pqo0abi6uC28W0XGj5cDWy7uJPbt61CFj6iLq6ehEIaKHVFgsbXyZ8gEGy8+Q76HcDSJZ6T2vap3yjrzBI8lTv/n0trusf4E+Zx5GivYM64YOojisn5wYIahWUZddx5pzppLzZyItwcc8n2PF1GvJy83Hl6z345GC6OOknwQKc2bcTh748jE27v0FmrjDUyYew80tTedY32PXVLZShAOf37MWuPd+AZnI1Zw5h+74Uk0Fu1PGJKM8Ugci5f+3Fzn9dQNKOvUi+no/Mi8ew67NjyBYn/dQqKnJx/LOtOJiSK/qUi3MHt2P76QKpCEhH0mf7cfDLndj8z1TkmfWdMJZnndyLYzfLgfvfi/7sxa6Tt0z1eMUEmIArEjBIMwV6FBQ8EsZeL53Uk1FXKh27uuvj4w1yIqWlFSLA0En69foyKc8VOXRpn0o9EBrhjay0G6ZuGHAxIx/h/cNN++ZVUev+oiIdhz7ei1O39eKEOV/Y7R04dN0gVdSc2IntR1Jxr6wcD9KSsfP/nTHesnP7GDZt2oHjF/OFrb+Bs4eEnMmWU0VN8k5sOpgqTphrob2YhO2f70fSiW9w5Z4obdNPiHLTEjjsRwjW5yNbZ8oQ3i0ztwjBg6IRTFllt4RP2Yo9p26IPuTi4hFqM034NSpsniT/liRm5RuKyCftRENW+jFs33sYh3Zux3+KcWVeTMb+nYdw6vR+fGLyWafEOHedF37KpEN7YT82f/41rggfnJf2NXZtPYyrFaZCXjGBx5xASz6CLg55eno4RMbDwx0nH93Gx9kpePncDsR8vR5rM7+Crtp1//mcGyAMiMWMnwRDm7IXG7bswuFz4iqM+URcoNWeOYpTZUMwf/E8zJw1A3GLJ6Nv/gWc0YhC06Kt64e4BDHrMGseEl4cAOSIqWcqGzoVy2dFIxD98PzrS7H89amIovwWEumYt0TomBOHWTEqFN+8DuWLS7FojmjzF2MRWpaLzDvGiplfHUVmwCQsWjQTM2fNxKL5T8P9UgquNPS7HOXKWCxbOg8zhb75o4JQfPu6FJBETV+KWcPE7MgTz2H566JP0wcblfInE2ACLkWgrKxCmg5+9KhYuvpDQYG5g+QQVKoA865d68BAFUiPuXJdXR1KxVQ0TTcXF5eKQKHBoJhFHut1r6EDoMy5jkzCIk72b94Pw1NP1IjT6UYsbfqLGzeQ7RWNqXMm4fnYGVj0ejxmDvEWlQuQIYKG8LHzMWPiBExdsBArF04wnpwPeg5xry1D/IIZwtbPw6JxISi+/gOyRS26GHQuzYCoafMw5dlnMGXBi4jyNEAZMwPjBwDt+wlJCaAegojgImTfMBgzKtKQdV+F/pFBoL/M5GPI9HwGi8ifkL9ZNAmhd7/B4QsmeRKyNYnjTPlCvDSuuMWT0L82H1e1TxvbED5rquDyICvdyFabgsNnyhE1Jx5xwgfPXBCPKU/k4/x3Bba2yvJMoEcRaM9HeHt7OTReqn9KBAhmJUUiMNiU/R1GJv8f/O+MY3hU1RjEm2W6eu3cAEGMJnzCPHHyPgdTBiuhSRFX9zftxdm7ogB6ZN4qgvKJAfDT61GsE0mvQnCgHtoHVG5Myt7hCDT3imYkjNk2fVrqCO+lAvz64aknTCp8veEtTGVZMe3fwM2cWoQMGIAa6g8ltyAEeurx6D6VG5OqTz94GDcRrFKatnjFBJiAqxOorq7Bw4dFoJN0mvZtqb90Yk8n+C2VNeS1s6FS+UtTztZiFIiQ46Hp5ZKSMtC+tcxjuR/+NCJV+ci8Dhiu3YLmiSEY7W1Joh1/0T8MwSKwSDp4Adlay9uLwtA31F34nv04nlYAuj20UasfRBwHw6NcXD19DEm3y+BRUS48E0nUoqbOHR6etE3JG96etTCU0bY8P0GSQBCe6q/Cgzs3pF3DtRw8UA3AUGlyJBfZd2sRGjUS0mwCSShjMDrSG5rbRnnKsj2pENrf3VjNLQTB/kDowMFQGnPg4yXAVpRJsyjFGbeg9QtDhFKPYvJ3IgUKP1usfWiS5hUTeLwIyPUR3t6eDoFReLrhzKOcZjoMdTXYmnMOY09uwF9vnkRJjQMXC5ppdyzDfCrumBbr2t5hGB47EwnL5+HZYC3OfZ2CYpSjslo4g7upOCGmbY3pe2gDBqCv2lpBZ+0bYKgBtNe/sejTLSC8H0J9O6sP3A4TYALOJkC3d1JQQMEBOYC29NO9ogEB/lAoFG2JtVnm66ts8+SfAoOSknLQjEJFhes4gDYH1aGFQRgRqUL2tQu4nPUQEcNirFprx18Ej8Wi12ZihNd1JH2+WbotNUs6mQeiZiQgbmIYis8fxKYN23HocpFRd9kNHN66GZ8cSkEeQhA1tB/EqbOxDDEYHmlA5ukLyBMnzXnnvsW1igGIkiaFbfMT4WJ2JPDuLWkWOjOnAIERQyDFB9BDTGTB27uxVWpcOoEv0cLiOhlld0gqN4hgqrIAFxp88Dc4p1Uhom9Qh7TXXZRyPx8/Arb6CE9PD4cgXS67j6o68f/Xipay2ip8mHUaPzn5D3ypudaKVOdmd0yAYB6DZwjGDxOmUV+EhwhDrwDA/YkxYnqXpngbE03hmqt07joEgf5AYNSLVn2KxfAuC1o6lwC3xgR6GgG6X7SwsAh05V7O2MhR1NTUgIIEOfLWMkqlH6i+dX5L+3V19aA3W+h0JW0GFC3V7Wl5gaOGIFTzPc4X9kPUEOvRyfAXqn54dnoclosLUcNr0pCUfMOkxB2hMZMwZ/EyxP8sBA9OHMVZHXD12DHkhE7GysXzMHXiSESFejfMDFPFQKUSSreHuChOni8WhmPqwhkYLl0ostFPhP8I/X01uHPzBu5o/ND/R2GkXiRxdV8FlAl/KHYalgdaPRAcgtCGHKuNOqt9B3bDg/0AzzA8O6vR/9LtvjPH93NAK1dlAt2LgD0+gi40eXl52jVQCi5OaW/LqltcXYlllxOxOu0/xQyouIItq1bHCLk5T20tMg9uxfYj6Wh4EVD1Q5y9poFHWD/0Fw1FDRuAWnG1/nheYxRVTMZRlMlaPEiqDMXNXhJN+fakMHHVSEwHn0/CFWGjjRpqodWWGzdlfLorhFCZXpq+FVu8MAEm0IUE6HahBw+KQMbclm5QvcBAcQXDlkomWbo9ieqbdmWt6I1HzT3xmQAAEABJREFUDx/qRGDRaAtlVexJQr4xiAqphXvk04hqwRO16S9up+Oq2WZ7BiM4wN1EpgiZV/JRY9oLDA1umCWoFajdPUxydXpkXclFsUkOKEBGdg36j5tqvFg0fQIiVebCMBv9RD9EPumBvJTvkec9EFEDGvX8OCoI2ivfNPibmrxkXLzrjsjoaKOQuX/GPQT7ewP3c3C1WmRQn/+VirwWWIlSecuQaETU3MCJrxoZQQQsxU4MQuR1hKWYQNcQIFttr4/wtvM5BKp3qlBegGCm8kV+Kqae3Yac8iJzVqevHTE1Vp11R9TkWAwsOYM9mzYafyht415cRjSmTo2RjLT3sBmY84wfbiZuxoZNW8X070bs/PICsuXOuIeMwej+elwUU8obNuzF2VI4/Bf+whxMjdDj1GcbsWHLVmz4+2bs+Spd9gl/6E9Gon9JKnZsEGPanQLTLLfD/WIFTIAJmAjIXNGtO/QQMt3OI7NKg5jBUA2VStWwb8sG1bM1ICH9NOtAt0AZDFW0+xgmb4yevwLL/1vDGXQTBm35izJDLs7vEDab/MjGzTheOBBTYgcDdQZoM5IkO76J7PnudHj8ZDLGixnhEaMGwyMrCR9uFHZ+035cVYYguKHFMDwlrmJd3W/yXR8adW8/mAZtHWCrn4igqEBbBI+Bg6WLY+ZmgifMEv5Gi+RtpF/4jMRb8Bs3HzPMMyhPhCDULR/JB9OlKt4xMYhwz8XxjaJfwuedCxiJ4f5SkX0fvtGYOesZ+GUdwoYNwgdv2owPdxzG+RyDffq4FhPoRgQc9RH2PodgcKsVFzRsfxFAZskD/NuZrThZeKtLKLs5tVXVjxA7fylWrYhH/GsLEb9cGP8FkxCpbGwlfMIcLF+5FAsXzENc/DKsfC0WEeIiCRCG2MUrEB9rno4VdcInIX7VTIwQm8bFDyPmiDpL4hD/+jyM9wfCYxdi1eJJpns8W9AxYqZFOWmJwZxVKzBnBG1T8kPU9IVYuTweC+fPw8LXRZ/nPmNyHNayQn7EzKb6lEJmxTIkvLoIyxaMhcVQhTAvTIAJdAaBkpIy6dYde9uiE3yl0hdubm42qXBzU8DT075pZ2qIghkKasrKKmm356dmNt1iyC2UteYvlEOnIn7lCiT8QviRhUuxaulURJHxdQvDePJByxchTtjz+OVLETfB5FMGvYgEYefjRR1az5w4FYvM/qUiHRdzVIhNELacfJdIC18ZCb/8b3Aqg/rYlp+gcqs08EUsF34m4cV+VgWkJ17ykQsXxEm+cP5Pghpl1GMRR318cYgxj07oly9DguhPgjSWGEwRfrLBf40Q/sg8BqmG0Qc2lIu88CY+UmQ8MRbzyc8tEuwWLMLKlQsxZZC3KOiahVtlAp1BwBk+wkPM8CkUdNuI/B4rFAp8q8+VX8FKkh5aXvD9bnyed8mqpON3bfOGcvvj6YdAtQqBrdkcN29judId9vx5KFVQetpTs4067fW5jaqAO5Rqvyb3s7YpzoVMgAk4jQD93gA9AOyoQgoSwsP7IDw8FBERTyI6ejBGjBiG0aNH4NlnR0lr2qf8QYMGCLk+CAsLRV0bD57J7VNxcYn0+lW58o+VXBv+wlvM+gSqWnA0JnvezE+Y8r2tPR+9NlURjFDhk5Tku6TkBx9h290t1Zvqt+rb5H4xJj3N+kH1qUz0gzaNyV34F5XTfZ7Ejv2WETF/9mgCzvQR/v6+oItJdEtqr15qhIYGCz/QC337hkhr2u/dWw21OgBm2Vtljt8X/z+vHsE/Nemd+j1Zm0k7GucqTIAJMIGuIUBvKiotlf/MkHUvPTw8EBjoLwx7b9B9ov3798WAAf3Rp08IVKoA+Pr6iBkCDygUCmlN+5QfGtpbyPXDk0/2Q0CAUsgHS2tbZyBg8UcPLz++txtZgOiKzZixGOFxHfu37cWhg4dF2ovtH59B2Y9nYGpkV3SI22QCTMAZBJztI8jek89QKn2Ez/AEzSqY7T6taZ8eZvbz8xE+xF8kJd56ahLO/XQlVot1by+lXcOqF7XeuJKI04+yxVbnLBwgdA5nboUJdE8CLtzr0tIK2W8qsh4GGfDgYJW4+hMkXQ2iW4WsZWzZd3d3FwGCnxQokPNwd7fPtGq1+sf7wWVboDtT1i0Msa8lIP6lsYgc0A+RI2Ix71dLETexH88MO5Mz62ICnUjAlXxEf181Vkc+jwsv/BrvD5uKMJ8Am0nU1tfjtYt7kVVWaHNdeyrY58XsaYnrMAEmwAScRICutOv1tr+lgK7u9OoVCJoC9vHxdlJvGtUoFAop4OjTp5c0M6FQKBoLZWyZn0mg16HKEGcRpxJwhzJkAIaPGonhg0KcfkuPU7vqJGWshgn0VAKu6iO83Nzxyyefwfmfvom/DJsGX3dPm76C8tpqvHphD+h1qDZVtEOYAwQ7oHEVJsAEuo5AbW0d6Eq7rT2ggCAkJEhMC3vZWtUueaXSF9QeBSW2KKB3dNPtRrbUYVkmwASYABMwEugOPsJD4YaFT47G/5+wBIOUvYwdl/mZW16EhNT97Uk7XM4BgsMIWQETYAKdSUBnx4+MBQQoQbcUKRS2XdF3dFwUHFCQQM832KKLrn7J/aE3W/SyLBNgAkygpxPoTj4iUtlbChIm9oqw6WuhZxH+750LNtWxVdjN1goszwSYQCcR4GaaEaAfGKOT52YFbWQEBamk5wPaEOnQIoVCAbqtiWYUbGlIry/j5xFsAcayTIAJPPYEuqOPULp74YsxcdKMgi1f4LsZx5BT7vgbklprkwOE1shwPhNgAi5HgH6oxsdH/i1CFBz4+jr/WQN7wNDDywEBfrKqipgCSqUP3O182FlWIyzUpQS4cSbABJxPoLv6CDdh9OmZBHqQWQ4VT4UbXhswBr29/OWI2yXDAYJd2LgSE2ACnU2AfgWTrqoHBgZIV+Tp9p22+hAY6A9XCQ7M/QwIUIJef2feb2lNtyOFhASLAMFX+vE3W2dMWtLJeUyACTCBnk7AhXyE3ajpVaiv9h/VZv3nekXg5MRlWPNULKr0FegoH8EBQptfAxcyASbgKgTolzDJATx4oEVVVY30ALBK5Y+WXlFKJ+FKpa+rdL1JPyhwod9faJIpdijgCQ4OlJ6VoGlyGmdlZRWc8SNwQj0vTIAJMIEeTaCn+Ig/R/8bhviHNPuuIpTB2DF6PvaOiUOvWm90tI/gAKHZV9CYUXAhEYn7EpGa35jHW48JAR6mSxGorDQ03I9PrwIlR0DGkW7BCQ0NbnJVnk6+1eoAl+q/ZWcUCoUUBJjzFAqF9GM6NGtQV1eH+/e1KC0tRz39Mo4QqqqqFleIqsXWY7gUpuJoUip0NbaMvRIZx8l2JyPD9jfh2tIQyzIBJuAiBHqSj/B288AnI+eA3nREeP09vLBmyGRp1mCCf/9O8xFODhAKkCpOqBP3HUWGjobVmCozk6WT7eTMysZMJ25V6gpQUKBDpU2OpO0OXPrHbMyeOxvrUtuW41ImwAQ6lgDdWmTdAr3Kjl4HSq88pdkCeluQl5cngoICrEVdbp9mC8y3G/XpEwzqd2FhEXS6ElCQYN3h0tIy66xuum/2EakosB5BfqrkIxIvmEuysX7qKEyfNgqxG2z59VANjv6WbPcKHDWrsmqLd5kAE+hZBHqaj3jKvzd++9TzmPvECJydtAJL+o2BrrC4U32EkwOES1gnTqhnz52OUW8ehWUooDm8QjrZXnFY0yFHZfKb4QgPH4+PcjpEfbtKX3jhBVy+fLldORZgAkzANgJ0Bb2mprbVSlT+8GGR9KvKwcEqeHp6tCort4BmKR49egSNRiMMstXVDqHk/v37OHz4MDIyMkC/WyCybF4CAvwQEKBEcXEpCgt1qK5u/eqGwVAt2qmzuQ3Xq2D2EetwybpzqeskHzH7H+aScIx/YSTU6pGYPdG2VwBaq7Z1n+25rcRYngl0HQHyARY+ollHqNwZPkKn00k+gfyCdSJ/QX7DsvHKykpJntaW+XK3f/OjiVg/7L/Dvay2S3yEkwOExmFXfr4Cazv2Fa2NjYlQRHxvFvudvzlp0iTMnj0bKSkpnd84t8gEejABeu5AzvDovn06kZYj257M+fPn8eSTT6Jv37749a9/3SBeXV2NZcuWISwsDC+99BKio6MxYsQIZGVlNcjYsmEwVEHu+CoqLC+52NJKd5X1wbgPLqGo6BLeeaZzx8D2vHN5c2tMwBECFRUGWdUd9RHkC8gntJTo/K+srAwUJFy5cgW/+c1vEBwcLPmQ48ePy+pfS0Jd6SM6JkAYOw7jkI33/n0b2p3hLfwOHyVMRnR/MQMwJg7rj1vWSMW2hCVYkrANqRbkUrdS3hJsowv2BUfxXkIc1kn8s7HrbYsyUccoS/V1+G5DHEaJdmZ/LtqoqURG0nq89dIohIu8cNH2R9/qRA37lnfffRevvvoqXn75ZZw4ccI+JVzLSIA/mYAFAbnG38PDHc54a1FpaSn++Mc/ihP3CoteGDe3bduGLVu2YO7cubhx4wZ27NiB7OxsLFmyBFTPKCX/08/PB+7u7rIqyOUgS1k3ETLab5Otb+hzJbL3rcH0McJn9I/G5AVGm79E+Ir3koRtb5DzEVu6Brsv2fgUeTae7blAxwsT6CYE5NpGR33E888/j6VLlzZJTz/9tESJfIC/v7+YyS6TLir9/e9/b9GHSMI2fHSlj+iYAMF3NmbPEgROrMDqw21c9cpcj/Hh47FiazKyxex65eXdeOvFcIz60Hy/qQbJW7dhmyi3vDFJc5rytiE5D0BpBnZtTUSq1EwlUvdZlIlio2wyDrw9CuPf3I3UfB3CI9Q4Gu+L6GlvYf3hDKBGh4ILu7FCTGMvSZIUiZq2L+RUEhISMGvWLBw9etR2BVyDCTCBJgRoarile/KbCJl26HYd06ZDq48//hhfffUVVq5cCT8/vwZdNE18+PBh6aoQ/a8/9dRT0kWBFStW4NSpU/j2228bZG3Z8PdvbKOtenQLkr23M7Wlt7PLbGnPaL9Ntl6qWClsdzgGzX0PR0tHYfpENdK/MNr8A0lHcDbHMqjT4aOpQSa7X2C08eMWY3eppKjdD/qO2Z63i4kFmECXEuhMH7F48WJ88sknDYlmFO7du4df/vKXmDdvnsSBgoSTJ09KMwkLFy6U8hz96Cof0TEBwkNg2tvvIAKV2P3mWqTWtIQnG+tfeQvf1aix4J9FqNBoUFQhppIHAqlvr8d3LVVpKS9yNdLrj2CBVDYU627WS1/MrhlShuljN97bHIGNaRWirAIbn/PBtP91BJ8ma1BRXwGNpgJFu6cJWR22bU4UvRabdi7vvvuuNLU0c+ZMHDhwwE4tXI0JMAEiQK/5pHV7iV516ozZg2vXruEvf/kLfvazn+GnP/1pkytANTU10tUhcgBqtVrqkkKhkORoWvn06dNSnq0ffn7eEGpkVZPLQ5ayLhXajTiaubVMC3e336OCXVj/mZgFGPgO0ji95bcAAA1CSURBVDOEDd99Fqn/GCfqqbF4nwZHlkWIbfOSjYqRn+J2RT3qq9OxdjjlJ+LICVrLS2zP5XFiKSZgItDpK7k20Vk+wjxAut30T3/6Ezw9PfHOO+9Ia3OZs9dd5SM6JkAQdHyeWYONr/oAOe9hzT4dIqJGilyLJScRu66K/YGLsXhMJQoKClBQGI7xU9VAZTLO2ndLr1DY8jLtbwfwxnDRH3Nx5DQsfiEMPqU6ZJxIRHIOIJVma2A5W2EWt2VNtx8MHjwYaWlptlRjWSbABKwI0FVzq6wWd318vFvMtyXTbPApEFi7di3odan15neNCkU+Pj7o3bs38vLycPHiRZEDKYAwXwjIz8+X8mz9UCgUoB9Hk1OPfv9Bjlx3kNHlC5tvmcR5f7v9FvZass/jRmGoSThsIAUFOhw9bZ55NhUIibfeX4wIH7HvMRSxL/iIDXEBKtNaTspu9YPteatouIAJdDmBzvQRloOl502//PJL0CxjZGSkZZHTtxWKrvERbk4fSYNCukq/Vpho4OjyNWKmoKHAuJF2yfhcQc56TA4PR7gpTd8sx0sYVdjyqe4tAg/LCvmJWDLSF4qAIETHzsbst4/C/puLGhWnp6dL9yePGjUKdPWpsaSbbHE3mYALEaCTdjndccbsQWJiojTr94c//AFjxoxp1iwFDL/61a/E1X4Ffv7zn6Nfv34ICQnBwYMHpbxmFWzIkBvgyOVhQ9NdJLoAR0TwRQFYQ/qncR4Ybf2JCzsvDxQCX6zFe1crpdtDE79IFBlqTJtIgYLYbGUJ6992eUvV2J63RIXzmIDrEJBrE53hI8yjJpu1fft26SLSjBlNblcxizh93RU+ogMDBMEncjW2rRQn5rqPsO5EEMJEVsMSHmHcD1uAjf9xAAeapI2Y1kS4oZZzNmq+w4qY2dh22QexH3wNTYmYgr65TgpmHGnA7Eyee+457Ny50xFVXJcJPPYEampqUVdn+rWwdmjQ7wi0I9JmMc0KrFmzBn369JGeMaBZgW9NzxTQQ8hJSUnSbMGUKVOkmcFXXnlFmk344IMPpAeVSXlgYCCt7Epy+09MyDnZ1QiA7l9vKNZ+vhpqcXlpTYy4wOMZhNlfVGLcH49izVg49Y/tuVNxsjIm4HQCZA87y0dYdp6eO6CX0URHR2PQoEGWRR223RU+omMDBIFq3J8/At3dn7h1G5rMDURFYzzEX0EqdDEv4+VXLFMshvqLMrH4igThDDLMtxxVZiDV8pVGUnk4ImwJKHLOIpk6M3wNPv1dLMKorRpxNUrSZd+H2ZnQCcSWLVvsU8K1mAATaCAgd+qY3kyhUCga6tmz8eDBA5DRp3db01sqKACgk3/SRc8WvP7669DpdLQrvdp0z549uHz5MpYvX46cnBzQSfuwYcOkcns+bBmDXC729MP162Rj/ar10E39FJqHGtD3VVRRj7N/Hgc1nPfH9tx5LFlTpxF47BqSawttsa9yINLv39y5cweDBw+GWq2WU8VhGVvGIJdLe53q8AAB6gXY+MFQoLISTU7B/Rdg7QcjRf8ysCYmGnF/3Y3EfR9hzUvRmLyhQOTTEotYafYmA2/NmI4lCXEYHxGNNfTsAhU3pKGIpufUkIG1y9dg977dSDYHFA0yFhthIqCg3asf4S3R7u6/xiE6Zo2oTZkWycO4/d1nu5FRY9xu7XPu3LnSe9E//PDD1kQ4nwkwARsI1NXJ+2EwuVdW2mqaXlV3+/ZtKUigQIESvcKU6syZMwfff/89QkNDpUCgqqqKsqX06NEjabZQrVZjwoQJUp69H15eJoPTjgK5XNpR002LM5BxQXT9u6PYdeIszp4+i+TDiUi+WgBdEwcjZBxY2J47AI+rMoFOIiDXFnp5eTq1R7du3ZJ8AV0UUigcuzhlS8e8OtlHdHyAIEYfsWob3lCLDatl6O+ScfaDlxEmTs13/3scZs9dgfeSigBdNoy23gcLPliHceQ3M49i29bd0P2PI7i9neYkLJUJufeNcrrj7yFubhzWJJmDDEs507YITtb9jSKKbCSKduPeTsbQvx0wveXCJCNWsa8sRphYZx9cjV2XxUYby8aNG/H++++3ISGjiEWYABNoIFAn8/YiNzfHzRi9iYJuLzI/C0XroKAgqS/0qlMKDuj3Cug5BXru4M0338SmTZukoICCB3pugZyFVMHODzc3eb+HIJeLnd1w8WrTsJouLOkS8dbc2cJnGNPkmHAE+YZjSVKlU/rP9twpGFkJE+hQAnJtoZsTfITlQGj2gPbdW/gNmxwxo0yvP01ISJBef01yGzZskB5mpltVad/e5ObWuT7Ccc/aZKTTsIsePEtbjQjLfI9x2FhUL0Vc6b+zLFFj3O8OQFNdgSKNRkwXF6GiWoOv/zgOPub6UatxtsJYXlRSj/S/TUPEa0ckXU1eZUpy1UY5TVEFzq4MkzRM21nfXFaUDF11FvUlRcY2KzQ4sPJlvJMmZC367kPT2BUkI2Y52vklT3ololDLCxNgAk4iUF8vbwbBza3zruDExMRgyJAhIIP/xhtv4ObNm6A3Hq1atQoKRdv9aA+L3HHUyZxZaa+9rimfZvQR9btgfZkHM3ZJtrp+Z2NJM/udvw0r3k7F0D9fErZbY0zZl3BgmZilRgG2fZEshhWB1WTL69OxOlLsmpaI36VL+pv6IFOh1YrtuRUQ3mUCLkigq3yE+Y119AyCNRaaVf7000+xdetW6fZTKj9+/Li0/8MPP9Cu3amzfYSTAwR7x+0DdVgYwsLUaAgMYPHn4SOVq/3Rzp8PJD3qFrWg2Z+/2tgmzVA0KzRl+JhkTLu8YgJMoHMI1MmcQVAoOsaM0dsp6sUFD/OtRjRquuf0/PnzKCoqkl7NTD+e5qx3YLu5yRuHXC7U356Wsvd9hOSaMEybMlLY7jBjGjgSsWOMF54iBhrXPW3cPB6XJ8Ad7AICcm2hs30E+QTyDeQjrIc9evRo6fdyqNw6/f73v7cWt2m/s32EPI9k0xBYmAkwASbgOAG1OgB9+4a0m5RKH3T2n1qtlt54RLcmOavtgAA/yBmvSqV0VpPdTk/EFDGDjAKsnxiOyQuWYEmCSC9FIyj+KBD5Bj79Lc0kdLthcYeZABOwg4Ar+wg7htNulc72ERwgmL8SXjMBJsAEmIBrExi+Fuk3j2Dda9HQnD6CI0lHcAnTsO4/LqEoYyNi1a7dfe4dE2ACTKC7EOAAobt8U9xPJsAE7CbAFXsOAZ/IaVj9yddIz9NAI9Klf67D6ldGQt3WraI9Z/g8EibABJhApxBw65RWuBEmwASYABNgAkyACTifAGtkAkygAwhwgNABUFklE2ACTIAJMAEmwASYABPorgRcI0DorvS430yACTABJsAEmAATYAJMoIcRaBYg0GuZetgYeThMgAl0IQFu2jUIOMu2O0uPa1DhXjABJsAEmAARsLbtTQIEd3c3yH2vLCnjxASYABNgAt2DANl2svGO9Jbqkx5HdHDdHkWAB8MEmEAPIUC2nWy8eThNAgRPTw8YDFXmMl4zASbABJhADyFAtp1svCPDofqkxxEdXJcJMAEmwARcjwDZdrLx5p65wbwl1j4+3qisNIgtXpgAE2ACTKAnESDbTjbekTFRfdLjiA6uywSYABNgAq5HgGw72Xhzz5rMIPj5+aC6ukbMIlSby3nNBJhANybAXWcCRMBgqJZsO9l42rc3UX32EfbS43pMgAkwAdck0JKPaBIgULcDApTQ60th/bAClXFiAkyACTCB7kWAbDnZdLLtzug56SF9pNcZ+liH3QS4IhNgAkzAYQJky8mmk223VNYsQKArRF5enigq0nOQYEmKt5kAE2AC3YwAGX6y5WTTybY7o/ukh/SRXtLvDJ2sgwkwASbABCwJdM422XCy5WTTybZbttosQKDCwEB/uLu7o7BQx7cbERBOTIAJMIFuRoCmjMmGky0nm+7M7pM+0kv6qR1n6mZdTIAJMAEm0PEEyHaTDSdbTjbdusUWAwQSImGl0hc6nR5abTHKyytRW1vHswoEhxMTkEGARZhAZxKgK0Fko8lWk80m2002nGx5R/SD9JJ+aofao3apfepHR7THOpkAE2ACTMB+AmSbyUaTrSabTbabbDjZ8pa0thogkDBNN/Tp0wv0VDM93VxYWASNphD37j3kxAz4GOBjgI8BFzoGyDaTjSZbTTabbDfZcLLlHZVIP7VD7VG71D714zHwEXzsu9Cxz8cbn5PxMdD+MUC2mWw02Wqy2WS7yYa35h/aDBDMlUhBcHAgSFnfviHgxAz4GOBjgI8B1zsGyEaTrSabbbbfnbGm9qhdap+PC9c7Lvg74e+EjwFbjoGeK0s2mmw12ez2fIOsAKE9JVzOBJgAE2ACTIAJMAEmwASYQM8gwAFCz/geeRRWBHiXCTABJsAEmAATYAJMwD4CHCDYx41rMQEmwASYQNcQ4FaZABNgAkyggwlwgNDBgFk9E2ACTIAJMAEmwASYgBwCLOMqBDhAcJVvgvvBBJgAE2ACTIAJMAEmwARcgMB/AQAA//9vn0fDAAAABklEQVQDAJYr2CkRAqtsAAAAAElFTkSuQmCC" width="624" height="60" alt="NYXH’s Sentiment Meter and Message Volume as of 7:56 a.m. ET on Nov. 26, 2025 | Source: Stocktwits"><figcaption>NYXH’s Sentiment Meter and Message Volume as of 7:56 a.m. ET on Nov. 26, 2025 | Source: Stocktwits</figcaption></figure><p><a href="https://stocktwits.com/symbol/NYXH">NYXH stock</a> fell 43% this year and by about 44% over the past 12 months.&nbsp;</p><p>Also See: <a href="https://stocktwits.com/news-articles/markets/equity/bytedance-reportedly-tops-chinese-nvidia-chip-buyers-but-now-it-can-t-use-them/cL53FkSREWe">Bytedance Reportedly Tops Chinese Nvidia Chip Buyers – But Now It Can't Use Them</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com</i></p>

Natalie Boller, 63, has a Genio Nyxoah bilateral hypoglossal nerve stimulator implant fitted for obstructive sleep apnoea. Picture date: Wednesday December 4, 2024. (Photo by Lucy North/PA Images via Getty Images)

Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy

Nyxoah expects the stronger reimbursement framework to support broader adoption, increase procedural throughput, and expand across Medicare-heavy institutions.

Equity

Cantor Fitzgerald Raises Earnings Estimates for Nyxoah

Nyxoah SA (NASDAQ:NYXH - Free Report) - Research analysts at Cantor Fitzgerald boosted their FY2025 earnings estimates for shares of Nyxoah in a report released on Wednesday, November 19th. Cantor...

Nyxoah (NASDAQ:NYXH) Posts Quarterly Earnings Results, Misses Expectations By $0.13 EPS

Nyxoah (NASDAQ:NYXH - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.74) EPS for the quarter, missing analysts' consensus estimates of ($0.60) by...

Nyxoah SA (NYXH) Reports Q3 Loss, Beats Revenue Estimates

Nyxoah (NYXH) delivered earnings and revenue surprises of -21.31% and +18.02%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates

Enovis (ENOV) delivered earnings and revenue surprises of +11.94% and +2.41%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

10x Genomics (TXG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Nyxoah SA (NYXH) to Report a Decline in Earnings: What to Look Out for

Nyxoah (NYXH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nyxoah Shares Rise on First U.S. Commercial Use of Genio System

NYXH's first U.S. commercial use of its Genio system signals strong physician demand and sets the stage for broad adoption in sleep apnea care.

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.

NYXH
Nyxoah SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NYXH News

NYXHNyxoah SA